BioNTech SE (BNTX) Tops Q1 EPS by 20c, provides guidance

BioNTech SE (NASDAQ: BNTX) reported Q1 EPS of (EUR1.95), EUR0.20 better than the analyst estimate of (EUR2.15). Revenue for the quarter came in at EUR118.1 million versus the consensus estimate of EUR185.6 million.

GUIDANCE:

BioNTech SE sees FY2026 revenue of EUR2-2.3 billion, versus the consensus of EUR2.185 billion.

For earnings history and earnings-related data on BioNTech SE (BNTX) click here.

You May Also Be Interested In

• Dataram (DRAM) call put ratio 1.4 calls to 1 put into SK Hynix plans to raise up to $29B
• HSBC Upgrades Gilead Sciences (GILD) to Buy
• InterContinental Hotels Group (IHG) PT Raised to $188 at BofA Securities